Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

Francois Venter talks about his unorthodox inaugural lecture, his work during the Aids crisis and his shoot-from-the-hip fix ...

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

In its latest budget request, the administration aims to slash 38 percent, or $2.9 billion, from the U.S. President’s ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

"This really has the possibility of ending HIV transmission," said Greg Millett, public policy director at The Foundation for ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...

GENEVA, 25 June 2025 — UNAIDS and Flanders have strengthened their joint efforts to combat the AIDS pandemic in Africa by signing a new cooperation agreement covering the period 2025—2026.

A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.

The adoption of the WHO Pandemic Agreement in May, 2025, marks a historic, if imperfect, milestone in global health governance.1 For African countries, which bore a disproportionate burden during the ...